Please provide your email address to receive an email when new articles are posted on . A review found that OCT and visual acuity were among the most popular benchmarks in the management of diabetic ...

Fundus photographs of eyes with diabetic macular edema (DME) could be used to estimate best-corrected visual acuity (BCVA) when artificial intelligence examines the pictures. Best-corrected visual ...

CONDOR randomized 689 adults with type 1/2 diabetes and PRP-naïve PDR across 152 sites in 16 countries; 572 completed the week-54 visit. Brolucizumab was administered q6w for three doses then q12w, ...

Please provide your email address to receive an email when new articles are posted on . A higher ADI score was linked with worse vision acuity after rhegmatogenous retinal detachment repair. This adds ...

The Diabetic Retinopathy Clinical Research Network (DRCR.net) conducted a comparative effectiveness trial evaluating the prevalence of persistent diabetic macular edema (DME) and its effect on visual ...

Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ® ...

Intravitreal brolucizumab is superior to panretinal laser photocoagulation in preserving visual acuity for patients with proliferative diabetic retinopathy, clinical trial data show.

Impaired vision and blindness are common. About 3.4 million people in the US are blind or visually impaired. Vision is usually measured by visual acuity charts, and normal vision is expressed as 20/20 ...